| Serial Number | 97424017 |
| Word Mark | IMMORNA |
| Filing Date | Monday, May 23, 2022 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Monday, June 24, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 31, 2023 |
| Goods and Services | Manufacture of nanoparticles and capsids for use in connection with mRNA-based therapeutics for others |
| Goods and Services | Messenger RNA (mRNA) pharmaceutical and biopharmaceutical preparations for use in the treatment of oncological diseases and disorders, infectious diseases, autoimmune and genetic diseases and disorders, and for use in medical cosmetology; messenger RNA (mRNA) pharmaceutical and biopharmaceutical preparations for vaccines; Pharmaceutical preparations and substances for the treatment of oncological diseases and disorders; Pharmaceutical preparations and substances for the treatment of infectious diseases; vaccines; pharmaceutical preparations and substances for the treatment of autoimmune diseases and disorders, autoimmune deficiency; pharmaceutical preparation and substances for the treatment of genetic disorders; pharmaceutical preparations and substances for use in medical cosmetology; diagnostic biomarker reagents for medical purposes; protein arrays for medical diagnosis purposes; diagnostic preparations for medical purposes for detecting the presence of tumors, infectious diseases, genetic disorders and autoimmune disorders and conditions; drug delivery agents in the form of polymer and lipid nanoparticles for delivery of mRNA being a pharmaceutical preparation; drug delivery agents in the form of nanoparticles and capsids for delivery for a wide variety of therapeutic agents |
| Goods and Services | Reagents for scientific, research, and medical research use; chemical reagents other than for medical purposes; diagnostic reagents for clinical or medical laboratory use; mRNA reagents for scientific, research, and medical research use; reagents comprised of nanoparticles for scientific, research, and medical research use; reagents, comprised of capsids for scientific, research, and medical research use |
| Goods and Services | Research and development of messenger RNA (mRNA) biotechnologies; Research and development services in the field of biologics, including but not limited to mRNA, RNA, DNA, antibodies, vaccines, and peptides; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostic services for scientific research purposes, and pharmacogenetics; conducting research and clinical trials for others in the field of biotechnology, pharmaceutical research and development, laboratory testing, diagnostic services for scientific research purposes, and pharmacogenetics; Scientific research, namely, mRNA synthesis, purification and testing |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 21, 2023 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 21, 2023 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 21, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 21, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Immorna Biotherapeutics Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Morrisville, NC 27560 |
| Party Name | Immorna Biotherapeutics Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Morrisville, NC 27560 |
| Event Date | Event Description |
| Thursday, May 26, 2022 | NEW APPLICATION ENTERED |
| Thursday, May 26, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, March 10, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, March 21, 2023 | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED |
| Tuesday, March 21, 2023 | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY |
| Tuesday, March 21, 2023 | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
| Tuesday, March 21, 2023 | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
| Tuesday, May 2, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, September 20, 2023 | ASSIGNED TO LIE |
| Thursday, September 21, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, September 21, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, September 21, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, October 11, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, October 31, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 31, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 26, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, June 24, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, June 25, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, June 25, 2024 | SOU EXTENSION 1 FILED |
| Tuesday, June 25, 2024 | SOU EXTENSION 1 GRANTED |
| Friday, December 20, 2024 | SOU TEAS EXTENSION RECEIVED |